ACS Applied Materials & Interfaces,
Journal Year:
2021,
Volume and Issue:
13(3), P. 3576 - 3590
Published: Jan. 15, 2021
The
plasmonic
properties
of
gold
nanoparticles
(AuNPs)
are
a
promising
tool
to
develop
sensing
alternatives
traditional,
enzyme-catalyzed
reactions.
need
for
alternatives,
especially
in
underdeveloped
areas
the
world,
has
given
rise
application
nonenzymatic
approaches
paired
with
cellulosic
substrates
biochemical
analysis.
Herein,
we
present
three
individual,
low-step,
wet-chemistry,
colorimetric
assays
target
biomarkers,
namely,
glucose,
uric
acid,
and
free
cholesterol,
relevant
diabetes
control
their
translation
into
paper-based
microfluidic
platforms
multiplexed
For
glucose
determination,
an
situ
AuNPs
synthesis
approach
was
applied
developed
μPAD,
giving
semiquantitative
measures
physiologically
range.
acid
cholesterol
modified
were
used
functionalize
paper
gold-on-paper
optical
changing
based
on
different
aggregation
degrees
hydrophobic
particles
dependent
analyte
concentration.
These
show
sensitivity
ranges
limits
detection
compatible
level
determination
comparable
those
similar
enzymatic,
systems,
relying
only
transduction
without
enzymatic
activity
or
other
chromogenic
substrates.
resulting
integrated
single
3D,
multiplex
device
using
microfluidics,
showing
capability
performing
distinct
requirements
terms
sample
flow
uptake
test
zones
combination
both
horizontal
vertical
flows
inside
same
device.
presented
allows
multiparametric,
metabolite
levels
from
complex
matrix
drop
digital
color
analysis,
potential
development
low-cost,
low-complexity
tools
diagnostics
toward
point-of-care.
Hypertension,
Journal Year:
2022,
Volume and Issue:
79(8), P. 1814 - 1823
Published: July 13, 2022
Uric
acid
(UA)
concentration
within
carotid
plaque
and
its
association
with
cerebrovascular
events
have
not
been
detected
or
quantified.
Systemically,
serum
UA
is
a
marker
of
inflammation
risk
factor
for
atherosclerosis.
However,
instability
stroke
pathogenesis
remains
unclear.
In
patients
undergoing
endarterectomy,
we
aimed
to
determine
whether
present
differentially
in
symptomatic
versus
asymptomatic
plaques
associated
symptoms
(stroke,
transient
ischemic
attack,
amaurosis
fugax).Carotid
atherosclerotic
were
collected
during
endarterectomy.
The
presence
was
assessed
using
Gomori
methenamine
silver
staining
as
well
anti-UA
immunohistochemical
quantity
measured
an
enzymatic
colorimetric
assay.
Clinical
information
obtained
through
retrospective
review
data.UA
more
commonly
(n=23)
compared
(n=9)
by
(20
[86.9%]
2
[22.2%];
P=0.001)
immunohistochemistry
(16
[69.5%]
1
[11.1%];
P=0.004).
higher
rather
than
(25.1
[9.5]
17.9
[3.8]
µg/g;
P=0.021).
Before
levels
(n=341)
(n=146)
(5.9
[interquartile
range,
4.6-6.9]
mg/dL
5.2
4.6-6.2]
mg/dL;
P=0.009).The
current
study
supports
potential
role
tissue
participant
systemic
biomarker
the
may
provide
mechanistic
explanation
subsequent
events.
Redox Biology,
Journal Year:
2021,
Volume and Issue:
48, P. 102195 - 102195
Published: Nov. 24, 2021
Cardiovascular
diseases
(CVD)
are
the
leading
cause
of
global
mortality
and
their
pathogenesis
lies
mainly
in
atherosclerotic
process.
There
close
connections
linking
oxidative
stress
inflammation
to
endothelial
dysfunction,
atherosclerosis
and,
consequently,
CVD.
This
review
focuses
on
role
xanthine
oxidoreductase
(XOR)
its
products
development
chronic
stress,
responsible
for
atheromatous
plaque
formation.
Evidence
is
reported
that
an
excessive
level
XOR
favors
inflammatory
response
development,
thereby
promoting
major
cardiovascular
risk
factors.
Also,
relationship
between
hyperuricemia
hypertension
as
well
activity
CVD
confirmed.
In
spite
increasing
number
clinical
studies
investigating
output
patients
treated
with
urate-lowering
therapies
(including
uricosuric
drugs,
inhibitors
recombinant
uricase)
results
still
uncertain.
The
inhibition
appears
more
promising
than
just
control
uricemia
preventing
events,
possibly
because
it
also
reduces
intracellular
accumulation
urate,
production
reactive
oxygen
species.
However,
availability
multifaced
mediator
nitric
oxide
at
present,
can
be
recommended
only
hyperuricemic
patients.
BMJ Open Respiratory Research,
Journal Year:
2024,
Volume and Issue:
11(1), P. e002203 - e002203
Published: March 1, 2024
Background
Chronic
obstructive
pulmonary
disease
(COPD)
and
hyperuricaemia
are
both
characterised
by
systemic
inflammation.
Preventing
chronic
diseases
among
the
population
with
common
metabolic
abnormality
is
an
effective
strategy.
However,
association
of
higher
incidence
risk
COPD
remains
controversial.
Therefore,
replicated
researches
in
populations
distinct
characteristics
or
demographics
compellingly
warranted.
Methods
This
cohort
study
adopted
a
design
ambispective
hospital-based
cohort.
We
used
propensity
score
matching
(PSM)
inverse
probability
treatment
weighting
(IPTW)
to
minimise
effects
potential
confounding
factors.
A
Cox
regression
model
restricted
cubic
spline
(RCS)
were
applied
further
assess
effect
serum
urate
on
developing
COPD.
Finally,
we
conducted
two-sample
Mendelian
randomisation
(MR)
analysis
explore
evidence
causal
association.
Results
There
compared
normal
(22.29/1000
person-years
vs
8.89/1000
person-years,
p=0.009).
result
robust
after
performing
PSM
(p=0.013)
IPTW
(p<0.001).
The
confirms
that
associated
(adjusted
HR=3.35
95%
CI=1.61
6.96).
Moreover,
RCS
shows
rapidly
increases
concentration
when
it
than
reference
(420
µmol/L).
MR
analysis,
variance
weighted
method
evidences
significant
(OR=1.153,
CI=1.034
1.289)
likely
be
true.
finding
repeated
using
different
methods
sensitivity
analysis.
Conclusions
Our
provides
convincing
suggesting
positive
between
COPD,
indicates
at
high
Chinese
who
seek
medical
advice
hospital.
Journal of Cellular and Molecular Medicine,
Journal Year:
2020,
Volume and Issue:
24(15), P. 8849 - 8861
Published: June 18, 2020
Abstract
Uric
acid
crystal
is
known
to
activate
the
NLRP3
inflammasome
and
cause
tissue
damages,
which
can
result
in
many
diseases,
such
as
gout,
chronic
renal
injury
myocardial
damage.
Meanwhile,
soluble
uric
(sUA),
before
forming
crystals,
also
related
these
diseases.
This
study
was
carried
out
investigate
whether
sUA
could
cardiomyocytes
analyse
mechanisms.
The
cardiomyocyte
activity
monitored,
along
with
levels
of
mature
IL‐1β
caspase‐1
from
H9c2
cells
following
stimulus.
We
found
that
able
inflammasome,
responsible
for
cell
apoptosis
induced
by
sUA.
By
elevating
TLR6
then
activating
NF‐κB/p65
signal
pathway,
promoted
NLRP3,
pro‐caspase
1
pro‐IL‐1β
production
provided
first
activation.
ROS
regulated
UCP2
contributed
assembly
subsequent
caspase
activation
secretion.
In
addition,
tlr6
knockdown
rats
suffering
hyperuricemia
showed
lower
level
an
ameliorative
cardiac
function.
These
findings
suggest
activates
they
may
provide
one
therapeutic
strategy
damage
Diabetes Research and Clinical Practice,
Journal Year:
2020,
Volume and Issue:
167, P. 108351 - 108351
Published: July 22, 2020
AimsCoronavirus
disease
(COVID-19),
also
referred
to
as
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
is
instigated
by
a
novel
coronavirus.
The
was
initially
reported
in
Wuhan,
China,
December
2019.
Diabetes
risk
factor
associated
with
adverse
outcomes.
Herein,
our
objective
investigate
the
characteristics
of
laboratory
findings
type
diabetes
mellitus
(T2DM)
patients
infected
SARS-CoV-2.MethodsThis
retrospective
study
and
included
80
T2DM
Jinling
Hospital
from
2010
2020,
well
76
COVID-19
without
55
who
were
treated
at
Huoshen
hill
February
11
March
18,
2020.
We
then
compared
differences
test
results
between
three
groups.ResultsThe
levels
lymphocytes,
uric
acid
(UA),
globulin
group
significantly
higher.
In
contrast,
C-reactive
protein
(CRP),
creatinine,
lactic
dehydrogenase
(LDH)levels
lower
than
those
(p
<
0.05)
+
groups
0.05).
No
considerable
difference
observed
regarding
alanine
aminotransferase
(ALT),
white
blood
cell
(WBC),
aspartate
(AST),
globulin,
urea
nitrogen
(BUN)
>
0.05).ConclusionT2DM
SARS-CoV-2
showed
decreased
body
mass
index
(BMI),
UA,
albumin,
increased
CRP
levels.
BMI,
albumin
may
be
oxidative
stress
response
nutritional
consumption.
lymphocyte
counts
related
infection.
Postgraduate Medicine,
Journal Year:
2024,
Volume and Issue:
136(6), P. 615 - 623
Published: July 8, 2024
Serum
uric
acid
(SUA)
has
garnered
an
increased
interest
in
recent
years
as
important
determinant
of
cardiovascular
disease.
Uric
acid,
a
degradation
product
purine
metabolism,
is
affected
by
several
inheritable
and
acquired
factors,
such
genetic
mutation,
metabolic
syndrome,
chronic
kidney
disease,
medication
interactions.
Even
though
elevated
SUA
have
been
commonly
associated
with
the
development
gout,
it
significant
impact
hypertension,
both
crystalline
soluble
forms,
plays
key
role
induction
inflammatory
cascade
atherosclerotic
diseases.
This
concise
reappraisal
emphasizes
features
about
complex
challenging
progression
atherosclerosis
It
explores
pathogenesis
historical
significance
highlights
interplay
between
components
focuses
on
pro-inflammatory
pro-atherogenic
effects
well
discusses
urate
lowering
therapies
mitigating
risk
disease
while
providing
latest
evidence
to
healthcare
professionals
focusing
clinical
importance
levels
regards